{"schema":"sb.node.v1","id":"sb:e/a13b7800e3c34a310e543c4c","kind":"entity","label":{"text":"phase ib","locale":"en"},"identity":{"anchor":"label:en:phase ib","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-23T15:03:43.007622+00:00","releaseId":"sb-676f61bea301","snapshot":"deploy b162a5100305d06d466370da038562b7cb51ebc9"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":30,"separatePublishers":13,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"measured","share":0.5,"named":15,"of":30,"basis":"documents whose own title or summary lead names the subject, over every counted document that mentions it anywhere (the entity graph's measurement); receipts are drawn only from rows whose own title or URL names the subject (the entity graph's subject gate)"}},"admission":{"state":"provisional","kind":"observed","kindBasis":"no-vocabulary-row","policy":"promotion (observed tier; not promoted)","reason":"seen recurring in the corpus and kept in the graph at the observation bar; not promoted into the vocabulary"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-03-11","to":"2026-10-22","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0: about 100% of mentions carry no typed assertion"]}},"dimensions":{"domains":["oncology"],"activeDays":22,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":6,"byKind":{"observation":6},"withheld":{"state":"withheld","count":1,"reason":"1 receipt withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/8af7a1fa266f629d533a8a9d","kind":"observation","label":"AllSci News · 2026-10-13 · First Tracks' ANB033 meets histologic endpoints in Phase Ib celiac disease trial","url":"https://allsci.com/news/clinical-trials/celiac-disease-trial-anb033-meets-key-histologic/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/404d9f5a668a350bb6632846","kind":"observation","label":"The Clinical Trial Vanguard · 2026-10-06 · Lundbeck’s Lu AF28996 gains 2+ hours daily ON-time in Parkinson’s Phase Ib","url":"https://www.clinicaltrialvanguard.com/news/lundbecks-lu-af28996-gains-2-hours-daily-on-time-in-parkinsons-phase-ib/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/c3c9e79b4442f09df7573919","kind":"observation","label":"Clinical Trials Arena · 2026-10-06 · First patient dosed in Vial’s Phase Ib trial of IL-13 x TSLP antibody","url":"https://www.clinicaltrialsarena.com/news/first-patient-dosed-vials-il-13-x-tslp-trial/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/80fce8a8ee8ce6e3768a0e83","kind":"observation","label":"The Clinical Trial Vanguard · 2026-10-02 · Lundbeck presents MSA trial baseline data, Lu AF28996 Phase Ib results at MDS 2026","url":"https://www.clinicaltrialvanguard.com/news/lundbeck-presents-msa-trial-baseline-data-lu-af28996-phase-ib-results-at-mds-2026/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/1eca564cf9b6f55ca58beee4","kind":"observation","label":"Clinical Trials Arena · 2026-09-25 · Clywedog reports final Phase Ib trial results for balomenib","url":"https://www.clinicaltrialsarena.com/news/clywedog-balomenib-phase-ib-trial-results/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/e05d37597498d982ad5b35b1","kind":"observation","label":"Clinical Trials Arena · 2026-09-22 · Alkermes reports positive top-line Phase Ib trial data for ALKS 7290","url":"https://www.clinicaltrialsarena.com/news/alkermes-positive-topline-alks-7290-trial-data/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}}],"cursor":null,"order":"newest first; we keep the 6 newest receipts for this entity whose own title or URL (the entity graph's subject gate) names it; each says which in match. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":3,"byKind":{"co-mentioned":3},"items":[{"kind":"relation","label":"co-mentioned with colorectal cancer (9 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/efa46a50047964a022d8d523"},{"kind":"relation","label":"co-mentioned with fda (9 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/df49d701c119f298a092ab96"},{"kind":"relation","label":"co-mentioned with immunotherapy (8 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/65b9d37be229384d85fc6185"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/a13b7800e3c34a310e543c4c","mcp":"traverse {\"id\":\"sb:e/a13b7800e3c34a310e543c4c\"}","page":"/entity/phase-ib/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/a13b7800e3c34a310e543c4c\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/a13b7800e3c34a310e543c4c\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"free-record","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/a13b7800e3c34a310e543c4c\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"free-record","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/a13b7800e3c34a310e543c4c\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"free-record","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history, which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"free-record","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"free-record","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"watch","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"watch","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"watch","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"watch","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"one-time-read","reason":"one-time Reads are not offered through this door; use ask"}]}